TLR9-mediated activation of dendritic cells by CD32 targeting for the generation of highly immunostimulatory vaccines

TLR9-mediated activation of dendritic cells by CD32 targeting for the generation of highly immunostimulatory vaccines

The rational for designing dendritic cell (DC)-targeted immunotherapies is their central role in orchestrating immunity. Most studies addressing antigen-targeting to DCs for eliciting T cell responses have employed ex-vivo matured DCs derived from monocytes or myeloid DCs isolated from peripheral bl...

Full description

Bibliographic Details
Main Authors: J. A. Sepulveda-Toepfer, Johannes Pichler, Kathrin Fink, Milica Sevo, Sonja Wildburger, Liesbeth Christiene Mudde-Boer, Christopher Taus, Geert Cornelius Mudde
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
vaccine
immunotherapy
cpg
cd32
plasmacytoid dendritic cells
Online Access:http://dx.doi.org/10.1080/21645515.2018.1514223

Internet

http://dx.doi.org/10.1080/21645515.2018.1514223

Similar Items